Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies.


Preclinical tests of therapeutic antibodies are frequently carried out in mice to evaluate pharmacokinetics and efficacy. However, the observation that mouse IgG are cleared rapidly from the human circulation suggests that mice may not always be an ideal model. The Fc receptor, FcRn, regulates the serum half-lives of IgG in mice and most likely has a… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.